Protagonist Therapeutics, Inc. ( PTGX) - Key Metrics
PTGX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.12 | -$0.70 | -$0.58 | -$0.56 |
| 2025Q3 | $0.07 | -$0.62 | -$0.03 | -$0.03 |
| 2025Q2 | $0.09 | -$0.55 | -$0.45 | -$0.47 |
| 2025Q1 | $0.45 | -$0.19 | $1.99 | $1.98 |
PTGX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -31.28 |
| 2025Q3 | ? | -26.92 |
| 2025Q2 | ? | -25.24 |
| 2025Q1 | ? | -65.31 |
PTGX
Price: $111.93
52 week price:
Earnings Per Share: -1.81 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 966400
Ebitda: -4.9 millionMarket Capitalization: 6.3 billion